Insulin glargine

Indications

• Rheumatoid arthritis
• Inflammatory bowel disease
• Psoriasis
• Certain types of cancer
• Multiple sclerosis
• Chronic obstructive pulmonary disease
• Asthma
• Hemophilia

Dosage

Adults: Dosage for biologics varies widely based on the specific agent and the condition being treated. Refer to specific product information for detailed dosing guidance.

Mechanism of action

Biologics exert their effects by targeting specific components of the immune system or specific pathways involved in disease processes. For example, monoclonal antibodies can bind to antigens on the surface of cells, blocking pathways that lead to inflammation or cell growth. Other biologics may modulate immune responses or deliver therapeutic genes directly to affected cells. The specificity of biologics often results in improved efficacy and reduced side effects compared to traditional small molecule drugs.

Pharmacodynamics

The pharmacodynamics of biologics is characterized by their ability to interact with specific biological targets, leading to a cascade of biochemical events that result in therapeutic effects. The response to biologics can be influenced by the presence of specific biomarkers, the immune status of the patient, and the pharmacogenomics of the individual. Their action is often dose-dependent, and the effects can vary based on the mechanism of action, whether it involves receptor blockade, immune modulation, or direct cellular effects.

Pharmacokinetics

Biologics typically have unique pharmacokinetic profiles that differ significantly from small molecules. They often have larger molecular weights and complex structures, affecting their absorption, distribution, metabolism, and excretion. Biologics are usually administered via injection due to their instability in the gastrointestinal tract. Their half-lives can vary widely, necessitating different dosing schedules. Factors such as patient age, body weight, and concomitant medications can influence the pharmacokinetics of biologics.

Adverse effects

• Injection site reactions
• Infections
• Allergic reactions
• Malignancies
• Hematologic abnormalities
• Autoimmune disorders

Interactions

• Live vaccines may be contraindicated
• Other immunosuppressive agents may increase risk of infections
• Methotrexate may have additive effects in some cases

Precautions

• Monitor for signs of infection
• Screen for latent tuberculosis before initiation
• Assess for history of malignancy
• Use caution in patients with heart failure

Pregnancy

Safety during pregnancy varies by specific biologic; consult relevant guidelines for individual agents.

Breast-feeding

Consult specific guidelines for individual biologics; some may be excreted in breast milk.

Storage

Typically stored in a refrigerator (2-8°C), do not freeze. Protect from light.

Formulations

• Injectable solutions
• Pre-filled syringes
• Vials for reconstitution

Indications

• Prevention of infectious diseases such as measles, mumps, rubella, polio, hepatitis B, and influenza.
• Immunization against bacterial infections like diphtheria, tetanus, and pertussis.
• Prophylaxis for diseases caused by pathogens like HPV (human papillomavirus) and varicella (chickenpox).

Dosage

Children: Paediatric doses vary based on age and vaccine type. Refer to guidelines for specific paediatric vaccination schedules.

Adults: Dosage varies depending on the specific vaccine, the individual's age, health status, and vaccination schedule. Refer to specific guidelines for each vaccine.

Mechanism of action

Vaccines work by introducing a harmless component of the pathogen (such as an inactivated virus, a live attenuated virus, or a piece of the pathogen) into the body. This triggers an immune response, which includes the activation of T-cells and the production of antibodies by B-cells. The immune system creates memory cells that respond more effectively upon subsequent exposure to the pathogen, thereby preventing disease.

Pharmacodynamics

Vaccination leads to the adaptive immune response, which includes both humoral immunity (antibody production) and cellular immunity (T-cell activation). The formation of memory T-cells and B-cells ensures long-lasting immunity. The response may take several weeks to develop but can provide protection against the disease for many years.

Pharmacokinetics

Vaccines are administered via various routes, including subcutaneous, intramuscular, or oral, depending on the type of vaccine. After administration, the vaccine components are processed by the immune system, leading to the activation and proliferation of lymphocytes. The half-life of antibodies produced may vary, with protective levels maintained through booster doses as recommended.

Contra-indications

• Severe allergic reaction (anaphylaxis) to a component of the vaccine
• Moderate or severe acute illness with or without fever
• History of encephalopathy within 7 days after a prior dose of a vaccine with a similar composition

Adverse effects

• Local reactions at the injection site (pain, redness, swelling)
• Fever
• Fatigue
• Headache
• Muscle pain
• Joint pain
• Allergic reactions (rash, urticaria)
• Very rarely, Guillain-Barré syndrome

Interactions

• Corticosteroids may diminish the effectiveness of live vaccines
• Immunosuppressive therapies can affect vaccine response
• Other vaccines may be administered simultaneously but in different sites

Precautions

• Patients with a history of seizures should be monitored
• Individuals with compromised immune systems may have reduced efficacy
• Pregnant individuals should consult healthcare providers before vaccination

Pregnancy

Safety during pregnancy varies by vaccine type; live vaccines are generally contraindicated.

Breast-feeding

Most vaccines are considered safe during breastfeeding; consult healthcare providers for specific vaccines.

Storage

Vaccines should be stored in a refrigerator between 2°C and 8°C. Avoid freezing.

Formulations

• Live attenuated vaccines
• Inactivated vaccines
• Subunit, recombinant, or conjugate vaccines
• mRNA vaccines